We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Elekta (EKTA B) Ser B NPV

Sell:60.45 SEK Buy:60.60 SEK Change: 0.15 SEK (0.25%)
Market closed |  Prices as at close on 23 December 2024 | Switch to live prices |
Sell:60.45 SEK
Buy:60.60 SEK
Change: 0.15 SEK (0.25%)
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
Market closed |  Prices as at close on 23 December 2024 | Switch to live prices |
Sell:60.45 SEK
Buy:60.60 SEK
Change: 0.15 SEK (0.25%)
Market closed |  Prices as at close on 23 December 2024 | Switch to live prices |
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Elekta publ AB is a Sweden-based human care company that develops and sells clinical solutions for the treatment of cancer and brain disorder. The Company offers and develops systems for radiation therapy and radio-surgery, as well as software systems that enhance workflow efficiency throughout the entire spectrum of cancer care. The Company has four product areas: Elekta Neuroscience, which develops solutions for the diagnosis and treatment of neurological diseases; Elekta Oncology, which creates clinical solutions for radiation therapy, such as linear accelerators, integrated imaging systems and clinical solutions for patient positioning and immobilization; Elekta Brachytherapy, which is engaged in the treatment of cancer through internal radiation, and Elekta Software, which develops software solutions for patient information, workflow management and treatment planning in oncology. The Company owns the service business of Asesores Electronicos Especializados SA de CV (AEESA).

Contact details

Address:
Kungstensgatan 18
STOCKHOLM
113 57
Sweden
Telephone:
+46 (8) 58725400
Website:
https://www.elekta.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
EKTA B
ISIN:
SE0000163628
Market cap:
22.28 billion SEK
Shares in issue:
382.08 million
Sector:
Health Care Equipment
Exchange:
Stockholm Stock Exchange
Country:
Sweden
Currency:
Swedish Krona
Indices:
n/a

Key personnel

  • Gustaf Salford
    President, Chief Executive Officer, Member of the Executive Committee
  • Tobias Haeggloev
    Chief Financial Officer, Member of the Executive Committee
  • Anna Lundgren
    Executive Vice President, Chief People Officer, Member of the Executive Committee
  • Jonas Bolander
    Executive Vice President - Group Functions, General Counsel, Member of the Executive Committee
  • John Lapre
    President - Brachy & Neuro Solutions, Member of the Executive Committee
  • Habib Nehme
    Chief Commercial Officer, Member of the Executive Committee
  • Maurits Wolleswinkel
    President - Linac & Software Solutions, Member of the Executive Committee

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Options

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.